Accelerating Transformation of Life Science, Pharma and Biotech R&D with Emerging Technology

21 May 2024

Boston, MA, USA

Discovery and development of medicines is resource intensive and extremely costly, with an estimated spend of $2.6 billion to bring a new drug to market. Recent reports suggest 70% of Pharma companies anticipate that smart technologies will positively enhance early discovery, R&D and quality operations, improving overall lab efficiency, productivity and accelerating time-to-market.

However, a combination of strategy, vision, infrastructure, mindset and talent is a prerequisite to drive these types of results and ensure the successful integration and implementation of data-centric, technology-driven, smart labs.

Join technology, service and solution providers at the Future Labs, Automation and Technology Summit on 23 May 2023 in Boston, USA to collaboratively share strategies to facilitate the transition to digitally optimized, connected smart labs of the future.

Expert Future Lab Automation & Technology 2023 Speakers

Olga Seltser of Laronde / Harbinger Health speaking at AMG World

Olga Seltser

Head of Automation/ VP Automation

Laronde / Harbinger Health

Jarrod Medeiros of Casma Therapeutics speaking at AMG World

Jarrod Medeiros

Senior Director Informatics & IT

Casma Therapeutics

Michael Nilsson of FORMULATRIX speaking at AMG World

Michael Nilsson

Assistant Director Liquid Handling

FORMULATRIX

Kristine Kearns of  Optimize Laboratory Consultants speaking at AMG World

Kristine Kearns

Chief Operating Officer

 Optimize Laboratory Consultants

Mary Belfast of Teva speaking at AMG World

Mary Belfast

Senior Manager Automation

Teva

Alex Main of Wise Construction speaking at AMG World

Alex Main

SVP, Operations

Wise Construction

Bill Olson of Columbia speaking at AMG World

Bill Olson

Vice President of Science & Technology

Columbia

Adriana Areas of AbbVie speaking at AMG World

Adriana Areas

Lab Informatics Manager

AbbVie

Dan Conway of PerkinElmer speaking at AMG World

Dan Conway

Principal Key Account Manager

PerkinElmer

Richard Welsh of Regeneron speaking at AMG World

Richard Welsh

Associate Director, Protein Expression Sciences Automation

Regeneron

Jeff Dillon of PerkinElmer speaking at AMG World

Jeff Dillon

Director of Enterprise Sales

PerkinElmer

Ed Hudak of Merck speaking at AMG World

Ed Hudak

Senior Director Robotics, Pre-Clinical Development

Merck

Gary Ritchie of CAI speaking at AMG World

Gary Ritchie

Principal Consultant

CAI

Ilja Kuesters of Generate Biomedicines speaking at AMG World

Ilja Kuesters

Senior Scientist, Assay Automation & Qualification

Generate Biomedicines

Kalpesh Gupta of Moderna speaking at AMG World

Kalpesh Gupta

Senior Principal Automation Engineer

Moderna

Jason Ekert of UCB speaking at AMG World

Jason Ekert

Head of US Discovery Translational Technology

UCB

Arvind Ramakrishnan of L7 Informatics speaking at AMG World

Arvind Ramakrishnan

VP of Research & Diagnostics Solutions

L7 Informatics

Leanna Duraj of Thermo Fisher Scientific speaking at AMG World

Leanna Duraj

Sr Product Specialist, Lab Automation

Thermo Fisher Scientific

Samuel Mohler of Aera Therapeutics speaking at AMG World

Samuel Mohler

Associate Director of Automation

Aera Therapeutics

Tuyen Nguyen of Alnylam Pharmaceuticals speaking at AMG World

Tuyen Nguyen

Principal Scientist, In Vitro Pharmacology HTS, Head of Lab Automation

Alnylam Pharmaceuticals

David Fuller of Artificial speaking at AMG World

David Fuller

CEO and Co-Founder

Artificial

Hema Downey of Thermo Fisher Scientific speaking at AMG World

Hema Downey

Manager OEM Sales, Lab Automation

Thermo Fisher Scientific

Vijay Nair of Bristol Myers Squibb speaking at AMG World

Vijay Nair

Director, R&D IT

Bristol Myers Squibb

Rishi Mahajan of Regeneron speaking at AMG World

Rishi Mahajan

Lead R&D Automation Engineer

Regeneron

Jesse Mulcahy of Orbital Therapeutics speaking at AMG World

Jesse Mulcahy

Director, Head of Lab Automation

Orbital Therapeutics

This summit will provide you with the necessary tools to:

  • Accelerate R&D to reduce time-to-market and lower costs through the application of automation, technology innovation, and digital tools within the lab for increased capacity, efficiency, flexibility, speed, and quality
  • Create the ecosystem and mindset for digital transition by combining talent, resources, and external partners to prepare, execute and scale the transition towards smart, connected labs of the future
  • Conduct an organizational capability assessment to determine digital strategy, and suitability for the integration of automation, digitally enhanced workflows, and technologically enhanced lab processes
  • Improve lab connectivity and cross-functional scientific collaboration with digitally optimized data capture, analysis and reuse that delivers actionable insights to improve speed and accuracy of scientific decision-making
  • Leverage emerging technology, data science, and digital innovations to unlock the possibilities of technology-supported drug discovery, research, and development

Who should attend:

Future Labs, Automation & Technology US 2023 is designed for VP’s, Directors, Heads and Managers from:

  • Automation / Robotics
  • R&D
  • Lab IT/ Research IT
  • Informatics
  • Technology & Innovation
  • Quality Assurance / Quality Control
  • Laboratory Operations & Strategy
  • Regulation, Compliance & Validation
  • Data & Analytics
  • Industry 4.0 / Lab 4.0
  • Emerging Technology / Artificial Intelligence (AI) / Machine Learning (ML

Our sponsors include technology, service & solution providers specializing in:

  • Laboratory Automation / Lab Digitalization
  • Robotics
  • Informatics
  • Data & Analytics
  • Artificial Intelligence (AI) / Machine Learning (ML)
  • Cloud Computing
  • IoT Hardware, Software, Platforms, Infrastructure
  • Cybersecurity

Become a Sponsor

GET IN TOUCH TO BE POSITIONED AS AN INDUSTRY EXPERT AMONGST THE MOST PROMINENT AND INFLUENTIAL PLAYERS IN THE DEVELOPMENT OF IOT, AI AND MACHINE LEARNING IN BIOPHARMA.

Our 2023 Sponsors

2023 Media Partners

Testimonials

GSK

Great interactive event indeed ; was pleased not only to attend but being able to share my own experience and meet colleagues and similarly interested people on the use of automation and AI/ML to accelerate drug development ! Thank you again for the event

Director R&D / GSK

Reckitt

Thanks for a great interactive event! Thanks for organising.

Senior IT Business Relationship Manager / Reckitt

AstraZeneca

It was a great meeting with lots to mull over. Thanks.

Director / AstraZeneca

Abbvie

It was great to participate in the panel discussion on the challenges and opportunities for developing smart labs and industrial automation in sustainable manner. Thanks AMG for the invite.

Director, Head of Enabling Technology Development Group / Abbvie

Amgen

Congratulations on conducting a great event! Many thanks for engaging me with it.

Director, Global Research (Biologics) / Amgen

Content Highlights

FLAT US Sponsorship Pack

Complete the form below to view the sponsorship information for the Future Labs, Automation & Technology Summit. Name First Last Job Title Organization(Required) Email(Required) NameThis field is for validation purposes and should be left unchanged.

Complimentary Interview: Accomplishing Lab Digitalisation

Ahead of the 2021 Summit, we shared this complimentary interview featuring GSK, AstraZeneca and BMS as they explore the phases, considerations and elements which must be balanced to accelerate the transition towards Lab 4.0 View the interview to discover: The Importance of digital strategy, culture & mindset Key considerations to develop universal data standards How… Read more »

Taking a Unified Approach to Digitally Transforming Scientific Discovery, Research and Development

Ahead of the Summit on 23 May 2023 in Boston, MA, we have made available this complimentary recording focused on Taking a Unified Approach to Digitally Transforming Scientific Discovery from the US virtual edition featuring smart labs experts from BMS, Biogen and Alnylam Pharmaceuticals. This discussion will explore the balance of infrastructure, resources, talent and… Read more »